This inventor holds 6 USPTO granted patents. Top assignee: Chirogate International Inc.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Innovations by Chun-Yu Lin: Pioneering Advances in Pharmaceutical Chemistry
Introduction
Chun-Yu Lin, based in Yangmei, Taiwan, is a distinguished inventor renowned for his contributions to pharmaceutical chemistry. With a remarkable portfolio of three patents, Lin focuses on developing novel processes and intermediates that contribute significantly to the preparation of important pharmaceutical compounds.
Latest Patents
Lin's latest patents include innovative methods related to the preparation of carbaprostacyclin analogues. These inventions detail processes for synthesizing carbaprostacyclin analogues along with the intermediates derived from these methods. Furthermore, his work incorporates the development of cyclopentenone intermediates available in both racemic and optically active forms.
Career Highlights
Chun-Yu Lin is affiliated with Chirogate International Inc., a company that specializes in advanced chemical solutions. His role entails pushing the boundaries of drug development through scientific inquiry and innovative thinking. Lin's commitment to research and development has positioned him as a prominent figure in the inventorship arena.
Collaborations
Throughout his career, Lin has collaborated with esteemed colleagues such as Tzyh-Mann Wei and Shih-Yi Wei. Their combined efforts have fostered a creative environment conducive to groundbreaking research and the advancement of pharmaceutical applications.
Conclusion
Chun-Yu Lin’s inventive spirit and dedication to innovation are evident in his impactful patents. His contributions to the field of pharmaceutical chemistry not only enhance existing methodologies but also pave the way for future advancements. As a forward-thinking inventor, Lin continues to inspire others through his remarkable achievements in drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile